Results 191 to 200 of about 337,580 (303)

HPV Biomarkers in Oral and Blood-Derived Body Fluids in Head and Neck Cancer Patients. [PDF]

J Med Virol
Galati L, Tagliabue M, Gheit T, De Berardinis R, Maffini F, McKay-Chopin S, De Palma G, Vecchio S, Paradiso AV, Sichero L, Villa LL, Chu F, Bandi F, Mossinelli C, Zocchi J, Pietrobon G, Zorzi SF, Grosso E, Riccio S, Bruschini R, Giugliano G, Blandino G, Tornesello ML, Ansarin M, Tommasino M, Chiocca S.   +25 more
europepmc   +1 more source

Indocyanine green fluorescence‐guided sentinel lymph node biopsy: A systematic review

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objectives Accurate staging of cervical lymph nodes is crucial in the management of head and neck cancers (HNCs). Sentinel lymph node biopsy (SLNB) offers a minimally invasive alternative to neck dissection for identifying occult metastases. This review aims to assess the feasibility and effectiveness of indocyanine green (ICG) fluorescence ...
Sanjena Venkatesh, Emma De Ravin, Karthik Rajasekaran   +2 more
wiley   +1 more source

De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence. [PDF]

Curr Oncol Rep
Chen AM.
europepmc   +1 more source

Application of Human Papillomavirus-DNA Test on Salivary Gland Fine Needle Aspiration Cytology Samples Confirms the Absence of the Virus in Primary Neoplasms and Demonstrates for the First Time Its Presence in Salivary Intraglandular Cysts. [PDF]

Diagn Cytopathol
Cozzolino I, Ronchi A, Montella M, Ruggiero R, Cappiello R, Savarese G, Colella G, Franco R.   +7 more
europepmc   +1 more source

The influence of tobacco use, hazardous drinking, and other risk factors on HPV-associated oropharyngeal cancer risk and screening perceptions among gay and bisexual men: a cross-sectional study. [PDF]

BMC Oral Health
Zoschke IN, Bennis SL, Tang Y, Wilkerson JM, Stull CL, Nyitray AG, Khariwala SS, Nichols CM, Rosser BRS, Flash CA, Ross MW.   +10 more
europepmc   +1 more source

Survivorship Needs and Experiences of Survivors of Head and Neck Cancer in Rural Australia: A Qualitative Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Semi‐structured interviews with 17 rural head and neck cancer survivors revealed six main themes relating to their survivorship needs and experiences: 1) financial impacts, 2) physical effects, 3) psychosocial effects, 4) clinical management, 5) information and support needs, and 6) access.
Poorva Pradhan, Helen Hughes, Ashleigh R. Sharman, Judith Lacey, Patrick Dwyer, Jacques Hill, Kimberley J. Davis, Steven Craig, Raymond Wu, Bruce Ashford, Jenny Mitchell, Jonathan R. Clark, Michael Elliott, Carsten E. Palme, Rebecca L. Venchiarutti   +14 more
wiley   +1 more source

Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis. [PDF]

Cancers (Basel)
Wierzbicka M, Pietruszewska W, Maciejczyk A, Markowski J.   +3 more
europepmc   +1 more source

Prevalence of HPV infection in the general population of young and adult males in Italy

Andrology, EarlyView.
Abstract Background The most prevalent sexually transmitted disease in the world has the human papillomavirus (HPV) as its etiological agent. Objectives To evaluate the prevalence of previous and actual HPV infection and the clinical manifestations in unselected males.
Giuseppe Grande, Andrea Graziani, Luca De Toni, Federica Finocchi, Adriano Presciutti, Sara Corrò, Alberto Ferlin, Andrea Garolla   +7 more
wiley   +1 more source

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021). [PDF]

Oral Dis
Sportiello L, La Mantia G, Panzarella V, Colella G, Potenza S, Oteri G, Sottosanti L, Bellavia G, Gaio M, Zinzi A, Morreale I, Parrinello G, Geninatti E, Marrazzo E, Fusco V, Capuano A, Campisi G.   +16 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source